{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:33:07Z","timestamp":1791549187917,"version":"4.3.4"},"reference-count":165,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"publisher","award":["5U19A109945-02"],"award-info":[{"award-number":["5U19A109945-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ebola viruses (EBOVs) and Marburg viruses (MARVs) are among the deadliest human viruses, as highlighted by the recent and widespread Ebola virus outbreak in West Africa, which was the largest and longest epidemic of Ebola virus disease (EVD) in history, resulting in significant loss of life and disruptions across multiple continents. Although the number of cases has nearly reached its nadir, a recent cluster of 5 cases in Guinea on March 17, 2016, has extended the enhanced surveillance period to June 15, 2016. New, enhanced 90-d surveillance windows replaced the 42-d surveillance window to ensure the rapid detection of new cases that may arise from a missed transmission chain, reintroduction from an animal reservoir, or more important, reemergence of the virus that has persisted in an EVD survivor. In this review, we summarize our current understanding of EBOV pathogenesis, describe vaccine and therapeutic candidates in clinical trials, and discuss mechanisms of viral persistence and long-term health sequelae for EVD survivors.<\/jats:p>","DOI":"10.1189\/jlb.4ri0316-099rr","type":"journal-article","created":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T23:14:33Z","timestamp":1472771673000},"page":"889-904","source":"Crossref","is-referenced-by-count":49,"title":["Molecular mechanisms of Ebola pathogenesis"],"prefix":"10.1093","volume":"100","author":[{"given":"Andrea","family":"Rivera","sequence":"first","affiliation":[{"name":"Division of Biomedical Sciences, University of California , Riverside, Riverside, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhem","family":"Messaoudi","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, University of California , Riverside, Riverside, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"key":"2023011710424646200_B1","first-page":"77","article-title":"Emerging and reemerging of filoviruses","volume":"11","author":"Feldmann","year":"1996","journal-title":"Arch. Virol. Suppl."},{"issue":"Suppl 2","key":"2023011710424646200_B2","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1086\/520551","article-title":"Forty years of Marburg virus","volume":"196","author":"Slenczka","year":"2007","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B3","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1055\/s-0028-1106144","article-title":"On the etiology of an unknown human infection originating from monkeys [in German]","volume":"92","author":"Siegert","year":"1967","journal-title":"Dtsch. Med. Wochenschr."},{"key":"2023011710424646200_B4","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1128\/JVI.00069-06","article-title":"Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola","volume":"80","author":"Towner","year":"2006","journal-title":"J. Virol."},{"key":"2023011710424646200_B5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJMoa051465","article-title":"Marburg hemorrhagic fever associated with multiple genetic lineages of virus","volume":"355","author":"Bausch","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"2023011710424646200_B6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(77)92000-1","article-title":"Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire","volume":"1","author":"Johnson","year":"1977","journal-title":"Lancet"},{"key":"2023011710424646200_B7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0140-6736(90)90737-P","article-title":"Preliminary report: isolation of Ebola virus from monkeys imported to USA","volume":"335","author":"Jahrling","year":"1990","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2023011710424646200_B8","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1086\/514285","article-title":"Human infection due to Ebola virus, subtype CoCte D\u2019Ivoire: clinical and biologic presentation","volume":"179","author":"Formenty","year":"1999","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B9","volume-title":"Outbreaks chronology: Ebola virus disease","author":"Centers for Disease Control and Prevention"},{"key":"2023011710424646200_B10","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3201\/eid2110.150259","article-title":"Delayed disease progression in cynomolgus macaques infected with Ebola virus Makona strain","volume":"21","author":"Marzi","year":"2015","journal-title":"Emerg. Infect. Dis."},{"issue":"Suppl 1","key":"2023011710424646200_B11","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1086\/514284","article-title":"Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epid\u00e9mies \u00e0 Kikwit","volume":"179","author":"Dowell","year":"1999","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2023011710424646200_B13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/514308","article-title":"Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients","volume":"179","author":"Bwaka","year":"1999","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B14","volume-title":"Fields Virology","author":"Knipe","year":"2013"},{"key":"2023011710424646200_B15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000149300","article-title":"Filoviridae: a taxonomic home for Marburg and Ebola viruses?","volume":"18","author":"Kiley","year":"1982","journal-title":"Intervirology"},{"key":"2023011710424646200_B16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0042-6822(02)00014-4","article-title":"Analysis of the role of predicted RNA secondary structures in Ebola virus replication","volume":"306","author":"Crary","year":"2003","journal-title":"Virology"},{"key":"2023011710424646200_B17","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1128\/JVI.72.11.8756-8764.1998","article-title":"Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes","volume":"72","author":"M\u00fchlberger","year":"1998","journal-title":"J. Virol."},{"key":"2023011710424646200_B18","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/JVI.73.3.2333-2342.1999","article-title":"Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems","volume":"73","author":"M\u00fchlberger","year":"1999","journal-title":"J. Virol."},{"key":"2023011710424646200_B19","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMcibr051754","article-title":"How Ebola virus infects cells","volume":"352","author":"Kawaoka","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"2023011710424646200_B20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0168-1702(93)90063-S","article-title":"Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus","volume":"29","author":"Sanchez","year":"1993","journal-title":"Virus Res."},{"key":"2023011710424646200_B21","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/jvi.67.3.1203-1210.1993","article-title":"Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein","volume":"67","author":"Will","year":"1993","journal-title":"J. Virol."},{"key":"2023011710424646200_B22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/viro.1998.9143","article-title":"Release of viral glycoproteins during Ebola virus infection","volume":"245","author":"Volchkov","year":"1998","journal-title":"Virology"},{"key":"2023011710424646200_B23","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1073\/pnas.93.8.3602","article-title":"The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing","volume":"93","author":"Sanchez","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023011710424646200_B24","doi-asserted-by":"crossref","DOI":"10.1006\/viro.1995.0052","article-title":"GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases","volume":"214","author":"Volchkov","year":"1995","journal-title":"Virology."},{"key":"2023011710424646200_B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-1702(92)90027-7","article-title":"Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle","volume":"24","author":"Feldmann","year":"1992","journal-title":"Virus Res."},{"key":"2023011710424646200_B26","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/JVI.76.10.4855-4865.2002","article-title":"Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP","volume":"76","author":"Noda","year":"2002","journal-title":"J. Virol."},{"key":"2023011710424646200_B27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00018-007-7406-2","article-title":"Filoviruses: Interactions with the host cell","volume":"65","author":"Dolnik","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"2023011710424646200_B28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0092-8674(01)00418-4","article-title":"Folate receptor-\u03b1 is a cofactor for cellular entry by Marburg and Ebola viruses","volume":"106","author":"Chan","year":"2001","journal-title":"Cell"},{"key":"2023011710424646200_B29","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1128\/JVI.75.3.1576-1580.2001","article-title":"Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies","volume":"75","author":"Ito","year":"2001","journal-title":"J. Virol."},{"key":"2023011710424646200_B30","doi-asserted-by":"crossref","first-page":"10194","DOI":"10.1128\/JVI.74.21.10194-10201.2000","article-title":"Functional importance of the coiled-coil of the Ebola virus glycoprotein","volume":"74","author":"Watanabe","year":"2000","journal-title":"J. Virol."},{"key":"2023011710424646200_B31","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1073\/pnas.95.11.6032","article-title":"The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil","volume":"95","author":"Weissenhorn","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023011710424646200_B32","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/JVI.72.4.3155-3160.1998","article-title":"Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines","volume":"72","author":"Wool-Lewis","year":"1998","journal-title":"J. Virol."},{"key":"2023011710424646200_B33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cell.2015.12.044","article-title":"Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1","volume":"164","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"2023011710424646200_B34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0042-6822(87)90283-2","article-title":"Identification and analysis of Ebola virus messenger RNA","volume":"157","author":"Sanchez","year":"1987","journal-title":"Virology"},{"key":"2023011710424646200_B35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0092-8674(81)90297-X","article-title":"VSV RNA synthesis: how can you be positive?","volume":"26","author":"Ball","year":"1981","journal-title":"Cell"},{"key":"2023011710424646200_B36","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1128\/JVI.76.17.8532-8539.2002","article-title":"Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation","volume":"76","author":"Weik","year":"2002","journal-title":"J. Virol."},{"key":"2023011710424646200_B37","volume-title":"Ebola and Marburg Viruses: Molecular and Cellular Biology","author":"Klenk","year":"2004"},{"key":"2023011710424646200_B38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"Bray","year":"1998","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jcpa.2001.0503","article-title":"Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus","volume":"125","author":"Bray","year":"2001","journal-title":"J. Comp. Pathol."},{"key":"2023011710424646200_B40","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.ppat.0020073","article-title":"Molecular determinants of Ebola virus virulence in mice","volume":"2","author":"Ebihara","year":"2006","journal-title":"PLoS Pathog."},{"key":"2023011710424646200_B41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1534\/genetics.111.132639","article-title":"The genome architecture of the Collaborative Cross mouse genetic reference population","volume":"190","author":"Collaborative Cross Consortium","year":"2012","journal-title":"Genetics"},{"key":"2023011710424646200_B42","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.1259595","article-title":"Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance","volume":"346","author":"Rasmussen","year":"2014","journal-title":"Science"},{"key":"2023011710424646200_B43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/infdis\/jiv538","article-title":"Humanized mouse model of Ebola virus disease mimics the immune responses in human disease","volume":"213","author":"Bird","year":"2016","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1242\/dmm.000471","article-title":"Disease modeling for Ebola and Marburg viruses","volume":"2","author":"Bente","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"2023011710424646200_B45","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"2023011710424646200_B46","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0002-9440(10)63592-4","article-title":"Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"2023011710424646200_B47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/labinvest.3780021","article-title":"Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses","volume":"80","author":"Geisbert","year":"2000","journal-title":"Lab. Invest."},{"key":"2023011710424646200_B48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-2478(01)00327-3","article-title":"Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily","volume":"80","author":"Hensley","year":"2002","journal-title":"Immunol. Lett."},{"key":"2023011710424646200_B49","doi-asserted-by":"crossref","first-page":"11025","DOI":"10.1128\/JVI.75.22.11025-11033.2001","article-title":"Infection and activation of monocytes by Marburg and Ebola viruses","volume":"75","author":"Str\u00f6her","year":"2001","journal-title":"J. Virol."},{"key":"2023011710424646200_B50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.2001.0836","article-title":"Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with Ebola virus secrete MIP-1\u03b1 and TNF-\u03b1 and inhibit poly-IC-induced IFN-\u03b1 in vitro","volume":"284","author":"Gupta","year":"2001","journal-title":"Virology"},{"key":"2023011710424646200_B51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2249.2002.01800.x","article-title":"Inflammatory responses in Ebola virus-infected patients","volume":"128","author":"Baize","year":"2002","journal-title":"Clin. Exp. Immunol."},{"issue":"Suppl 3","key":"2023011710424646200_B52","doi-asserted-by":"crossref","first-page":"S991","DOI":"10.1093\/infdis\/jir336","article-title":"Host response dynamics following lethal infection of rhesus macaques with Zaire Ebolavirus","volume":"204","author":"Ebihara","year":"2011","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B53","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1128\/JVI.78.19.10370-10377.2004","article-title":"Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels","volume":"78","author":"Sanchez","year":"2004","journal-title":"J. Virol."},{"issue":"Suppl 1","key":"2023011710424646200_B54","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1086\/514283","article-title":"Markedly elevated levels of interferon (IFN)-\u03b3, IFN-\u03b1, interleukin (IL)-2, IL-10, and tumor necrosis factor-\u03b1 associated with fatal Ebola virus infection","volume":"179","author":"Villinger","year":"1999","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B55","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis","volume":"4","author":"Wauquier","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2023011710424646200_B56","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1128\/JVI.75.10.4649-4654.2001","article-title":"Passive transfer of antibodies protects immunocompetent and immunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication","volume":"75","author":"Gupta","year":"2001","journal-title":"J. Virol."},{"key":"2023011710424646200_B57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1009657006550","article-title":"Apoptosis in fatal Ebola infection: does the virus toll the bell for immune system?","volume":"5","author":"Baize","year":"2000","journal-title":"Apoptosis"},{"key":"2023011710424646200_B58","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1086\/379724","article-title":"Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes\/macrophages is a key event","volume":"188","author":"Geisbert","year":"2003","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B59","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.4049\/jimmunol.170.6.2797","article-title":"Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses","volume":"170","author":"Mahanty","year":"2003","journal-title":"J. Immunol."},{"key":"2023011710424646200_B60","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1086\/379199","article-title":"Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation","volume":"188","author":"Bosio","year":"2003","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B61","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1128\/JVI.03316-12","article-title":"The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains","volume":"87","author":"Lubaki","year":"2013","journal-title":"J. Virol."},{"key":"2023011710424646200_B62","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/JVI.02199-05","article-title":"Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha\/beta interferon production induced by RIG-I signaling","volume":"80","author":"C\u00e1rdenas","year":"2006","journal-title":"J. Virol."},{"key":"2023011710424646200_B63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.chom.2013.06.010","article-title":"Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome","volume":"14","author":"Luthra","year":"2013","journal-title":"Cell Host Microbe"},{"key":"2023011710424646200_B64","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1128\/JVI.77.14.7945-7956.2003","article-title":"The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3","volume":"77","author":"Basler","year":"2003","journal-title":"J. Virol."},{"key":"2023011710424646200_B65","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1128\/JVI.01875-08","article-title":"Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKK and TBK-1","volume":"83","author":"Prins","year":"2009","journal-title":"J. Virol."},{"key":"2023011710424646200_B66","doi-asserted-by":"crossref","first-page":"e1000493","DOI":"10.1371\/journal.ppat.1000493","article-title":"Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery","volume":"5","author":"Chang","year":"2009","journal-title":"PLoS Pathog."},{"key":"2023011710424646200_B67","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1128\/JVI.02459-09","article-title":"Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs","volume":"84","author":"Prins","year":"2010","journal-title":"J. Virol."},{"key":"2023011710424646200_B68","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1128\/JVI.01372-09","article-title":"Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling","volume":"84","author":"Mateo","year":"2010","journal-title":"J. Virol."},{"key":"2023011710424646200_B69","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.02349-05","article-title":"Ebola virus VP24 binds karyopherin \u03b11 and blocks STAT1 nuclear accumulation","volume":"80","author":"Reid","year":"2006","journal-title":"J. Virol."},{"key":"2023011710424646200_B70","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1128\/JVI.01097-07","article-title":"Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin \u03b1 proteins with activated STAT1","volume":"81","author":"Reid","year":"2007","journal-title":"J. Virol."},{"key":"2023011710424646200_B71","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.chom.2014.07.008","article-title":"Ebola virus VP24 targets a unique NLS binding site on karyopherin \u03b15 to selectively compete with nuclear import of phosphorylated STAT1","volume":"16","author":"Xu","year":"2014","journal-title":"Cell Host Microbe"},{"key":"2023011710424646200_B72","first-page":"140","article-title":"Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure","volume":"120","author":"Jaax","year":"1996","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"Suppl 2","key":"2023011710424646200_B73","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1086\/520602","article-title":"Lymphocyte death in a mouse model of Ebola virus infection","volume":"196","author":"Bradfute","year":"2007","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/vim.2004.17.390","article-title":"Depletion of peripheral blood T lymphocytes and NK cells during the course of Ebola hemorrhagic fever in cynomolgus macaques","volume":"17","author":"Reed","year":"2004","journal-title":"Viral Immunol."},{"key":"2023011710424646200_B75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virol.2007.02.017","article-title":"Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro","volume":"364","author":"Gupta","year":"2007","journal-title":"Virology"},{"key":"2023011710424646200_B76","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"Baize","year":"1999","journal-title":"Nat. Med."},{"key":"2023011710424646200_B77","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4049\/jimmunol.0901231","article-title":"Mechanisms and consequences of Ebolavirus-induced lymphocyte apoptosis","volume":"184","author":"Bradfute","year":"2010","journal-title":"J. Immunol."},{"key":"2023011710424646200_B78","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1023\/A:1020546615229","article-title":"TNF-induced signaling in apoptosis","volume":"19","author":"Rath","year":"1999","journal-title":"J. Clin. Immunol."},{"key":"2023011710424646200_B79","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1009616228304","article-title":"Role of reactive oxygen species (ROS) in apoptosis induction","volume":"5","author":"Simon","year":"2000","journal-title":"Apoptosis"},{"key":"2023011710424646200_B80","doi-asserted-by":"crossref","first-page":"e7059","DOI":"10.1371\/journal.pone.0007059","article-title":"Nitric oxide induces cell death by regulating anti-apoptotic BCL-2 family members","volume":"4","author":"Snyder","year":"2009","journal-title":"PLoS One"},{"key":"2023011710424646200_B81","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1411249","article-title":"Clinical presentation of patients with Ebola virus disease in Conakry, Guinea","volume":"372","author":"Bah","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2023011710424646200_B82","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2249.2001.01517.x","article-title":"Early immune responses accompanying human asymptomatic Ebola infections","volume":"124","author":"Leroy","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"2023011710424646200_B83","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.4049\/jimmunol.180.6.4058","article-title":"Functional CD8+ T cell responses in lethal Ebola virus infection","volume":"180","author":"Bradfute","year":"2008","journal-title":"J. Immunol."},{"key":"2023011710424646200_B84","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1128\/JVI.76.24.12463-12472.2002","article-title":"Covalent modifications of the Ebola virus glycoprotein","volume":"76","author":"Jeffers","year":"2002","journal-title":"J. Virol."},{"key":"2023011710424646200_B85","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/78654","article-title":"Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury","volume":"6","author":"Yang","year":"2000","journal-title":"Nat. Med."},{"key":"2023011710424646200_B86","doi-asserted-by":"crossref","first-page":"e1001098","DOI":"10.1371\/journal.ppat.1001098","article-title":"Steric shielding of surface epitopes and impaired immune recognition induced by the Ebola virus glycoprotein","volume":"6","author":"Francica","year":"2010","journal-title":"PLoS Pathog."},{"key":"2023011710424646200_B87","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"2023011710424646200_B88","doi-asserted-by":"crossref","first-page":"9596","DOI":"10.1128\/JVI.00784-09","article-title":"Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins","volume":"83","author":"Reynard","year":"2009","journal-title":"J. Virol."},{"key":"2023011710424646200_B89","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1128\/JVI.02190-10","article-title":"A new Ebola virus nonstructural glycoprotein expressed through RNA editing","volume":"85","author":"Mehedi","year":"2011","journal-title":"J. Virol."},{"key":"2023011710424646200_B90","doi-asserted-by":"crossref","first-page":"e1003065","DOI":"10.1371\/journal.ppat.1003065","article-title":"Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus","volume":"8","author":"Mohan","year":"2012","journal-title":"PLoS Pathog."},{"key":"2023011710424646200_B91","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1073\/pnas.1502619112","article-title":"Human Ebola virus infection results in substantial immune activation","volume":"112","author":"McElroy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023011710424646200_B92","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature17949","article-title":"Unique human immune signature of Ebola virus disease in Guinea","volume":"533","author":"Ruibal","year":"2016","journal-title":"Nature"},{"key":"2023011710424646200_B93","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1128\/jvi.70.4.2208-2214.1996","article-title":"Filovirus-induced endothelial leakage triggered by infected monocytes\/macrophages","volume":"70","author":"Feldmann","year":"1996","journal-title":"J. Virol."},{"key":"2023011710424646200_B94","first-page":"138","article-title":"Hypotension during hemodialysis: role for nitric oxide","volume":"313","author":"Kang","year":"1997","journal-title":"Am. J. Med. Sci."},{"key":"2023011710424646200_B95","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1161\/01.ATV.17.12.3399","article-title":"Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity","volume":"17","author":"Neumann","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2023011710424646200_B96","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S1473-3099(15)70152-0","article-title":"Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study","volume":"15","author":"Clark","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"2023011710424646200_B97","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1473-3099(15)00489-2","article-title":"Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study","volume":"16","author":"Mattia","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"2023011710424646200_B98","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/cid\/civ453","article-title":"Study of Ebola virus disease survivors in Guinea","volume":"61","author":"Qureshi","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"2023011710424646200_B99","article-title":"Ebola RNA persistence in semen of Ebola virus disease survivors\u2014preliminary report","author":"Deen","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2023011710424646200_B100","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1509773","article-title":"Molecular evidence of sexual transmission of Ebola virus","volume":"373","author":"Mate","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2023011710424646200_B101","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1500306","article-title":"Persistence of Ebola virus in ocular fluid during convalescence","volume":"372","author":"Varkey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2023011710424646200_B102","article-title":"Ebola survivor from Scotland is critically ill","author":"Fink","year":"14, 2015","journal-title":"N. Y. Times."},{"key":"2023011710424646200_B103","doi-asserted-by":"crossref","first-page":"20983","DOI":"10.2807\/1560-7917.ES2014.19.49.20983","article-title":"Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014","volume":"19","author":"Baggi","year":"2014","journal-title":"Euro Surveill."},{"key":"2023011710424646200_B104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000099237","article-title":"Regional immunity and immune privilege","volume":"92","author":"Kaplan","year":"2007","journal-title":"Chem. Immunol. Allergy"},{"key":"2023011710424646200_B105","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1172\/JCI83162","article-title":"Ebola viral load at diagnosis associates with patient outcome and outbreak evolution","volume":"125","author":"De La Vega","year":"2015","journal-title":"J. Clin. Invest."},{"key":"2023011710424646200_B106","doi-asserted-by":"crossref","first-page":"e0004113","DOI":"10.1371\/journal.pntd.0004113","article-title":"Prognostic analysis of patients with Ebola virus disease","volume":"9","author":"Zhang","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2023011710424646200_B107","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa1411680","article-title":"Clinical illness and outcomes in patients with Ebola in Sierra Leone","volume":"371","author":"Schieffelin","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 2","key":"2023011710424646200_B108","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1086\/520613","article-title":"Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus","volume":"196","author":"Rollin","year":"2007","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B109","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"2023011710424646200_B110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.antiviral.2014.07.004","article-title":"HSPA5 is an essential host factor for Ebola virus infection","volume":"109","author":"Reid","year":"2014","journal-title":"Antiviral Res."},{"key":"2023011710424646200_B111","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1074\/mcp.M110.003418","article-title":"Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen","volume":"9","author":"Spurgers","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"issue":"Suppl 2","key":"2023011710424646200_B112","doi-asserted-by":"crossref","first-page":"S329","DOI":"10.1086\/520588","article-title":"Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: identification of alleles associated with fatal and nonfatal disease outcomes","volume":"196","author":"Sanchez","year":"2007","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B113","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00251-010-0480-x","article-title":"Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection","volume":"62","author":"Wauquier","year":"2010","journal-title":"Immunogenetics"},{"key":"2023011710424646200_B114","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/v4091619","article-title":"Potential vaccines and post-exposure treatments for filovirus infections","volume":"4","author":"Friedrich","year":"2012","journal-title":"Viruses"},{"key":"2023011710424646200_B115","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1371\/journal.pmed.0030177","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs","volume":"3","author":"Sullivan","year":"2006","journal-title":"PLoS Med."},{"key":"2023011710424646200_B116","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.2447","article-title":"CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates","volume":"17","author":"Sullivan","year":"2011","journal-title":"Nat. Med."},{"key":"2023011710424646200_B117","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vaccine.2010.10.037","article-title":"A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults","volume":"29","author":"Ledgerwood","year":"2010","journal-title":"Vaccine"},{"key":"2023011710424646200_B118","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/S0140-6736(15)60553-0","article-title":"Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"385","author":"Zhu","year":"2015","journal-title":"Lancet"},{"key":"2023011710424646200_B119","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against Ebolavirus challenge","volume":"85","author":"Geisbert","year":"2011","journal-title":"J. Virol."},{"key":"2023011710424646200_B120","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against Ebolavirus challenge","volume":"20","author":"Stanley","year":"2014","journal-title":"Nat. Med."},{"key":"2023011710424646200_B121","article-title":"Chimpanzee adenovirus vector Ebola vaccine\u2014preliminary report","author":"Ledgerwood","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2023011710424646200_B122","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMoa1411627","article-title":"A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA","volume":"374","author":"Ewer","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"2023011710424646200_B123","volume-title":"PREVAIL phase2\/3 clinical trial of investigational Ebola vaccines","author":"National Institute of Allergy and Infectious Diseases"},{"key":"2023011710424646200_B124","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat. Med."},{"issue":"Suppl 2","key":"2023011710424646200_B125","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1086\/520591","article-title":"Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever","volume":"196","author":"Jones","year":"2007","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B126","doi-asserted-by":"crossref","first-page":"e5547","DOI":"10.1371\/journal.pone.0005547","article-title":"Mucosal immunization of cynomolgus macaques with the VSV\u0394G\/ZEBOVGP vaccine stimulates strong Ebola GP-specific immune responses","volume":"4","author":"Qiu","year":"2009","journal-title":"PLoS One"},{"key":"2023011710424646200_B127","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1016\/j.vaccine.2014.08.028","article-title":"Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents","volume":"32","author":"Wong","year":"2014","journal-title":"Vaccine"},{"key":"2023011710424646200_B128","doi-asserted-by":"crossref","first-page":"e94355","DOI":"10.1371\/journal.pone.0094355","article-title":"Durability of a vesicular stomatitis virus-based Marburg virus vaccine in nonhuman primates","volume":"9","author":"Mire","year":"2014","journal-title":"PLoS One"},{"key":"2023011710424646200_B129","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1073\/pnas.1209591110","article-title":"Antibodies are necessary for rVSV\/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates","volume":"110","author":"Marzi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023011710424646200_B130","doi-asserted-by":"crossref","first-page":"e1000225","DOI":"10.1371\/journal.ppat.1000225","article-title":"Vesicular stomatitis virus-based Ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates","volume":"4","author":"Geisbert","year":"2008","journal-title":"PLoS Pathog."},{"key":"2023011710424646200_B131","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1128\/JVI.00561-09","article-title":"Single-injection vaccine protects nonhuman primates against infection with Marburg virus and three species of Ebola virus","volume":"83","author":"Geisbert","year":"2009","journal-title":"J. Virol."},{"key":"2023011710424646200_B132","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007","journal-title":"PLoS Pathog."},{"key":"2023011710424646200_B133","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/JVI.00456-08","article-title":"Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates","volume":"82","author":"Geisbert","year":"2008","journal-title":"J. Virol."},{"key":"2023011710424646200_B134","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"Ebola Vaccine: VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain","volume":"349","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"2023011710424646200_B135","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe\u2014preliminary report","author":"Agnandji","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2023011710424646200_B136","article-title":"A recombinant vesicular stomatitis virus Ebola vaccine\u2014preliminary report","author":"Regules","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2023011710424646200_B137","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"issue":"Suppl 3","key":"2023011710424646200_B138","doi-asserted-by":"crossref","first-page":"S785","DOI":"10.1093\/infdis\/jir298","article-title":"Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany","volume":"204","author":"G\u00fcnther","year":"2011","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B139","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.2015.1995","article-title":"Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick","volume":"313","author":"Lai","year":"2015","journal-title":"JAMA"},{"key":"2023011710424646200_B140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (Favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antiviral Res."},{"key":"2023011710424646200_B141","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2014.01.012","article-title":"Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model","volume":"104","author":"Smither","year":"2014","journal-title":"Antiviral Res."},{"key":"2023011710424646200_B142","volume-title":"First French Ebola patient leaves hospital","author":"Trompiz"},{"key":"2023011710424646200_B143","doi-asserted-by":"crossref","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment with Favipiravir for Ebola virus disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea [published correction in PLoS Med. (2016) 13, e1002009]","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med."},{"key":"2023011710424646200_B144","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"2023011710424646200_B145","volume-title":"A Phase 1 study to evaluate the safety, tolerability and pharmacokinetics of BCX4430","author":"U.S. National Institutes of Health"},{"key":"2023011710424646200_B146","doi-asserted-by":"crossref","first-page":"38","DOI":"10.12688\/f1000research.6120.1","article-title":"Small molecules with antiviral activity against the Ebola virus","volume":"4","author":"Litterman","year":"2015","journal-title":"F1000 Res."},{"key":"2023011710424646200_B147","doi-asserted-by":"crossref","first-page":"h664","DOI":"10.1136\/bmj.h664","article-title":"Ebola drug trial is terminated after fall in number of new cases","volume":"350","author":"Gulland","year":"2015","journal-title":"BMJ"},{"key":"2023011710424646200_B148","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"2023011710424646200_B149","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.2202","article-title":"Advanced antisense therapies for postexposure protection against lethal filovirus infections","volume":"16","author":"Warren","year":"2010","journal-title":"Nat. Med."},{"key":"2023011710424646200_B150","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1128\/AAC.03442-14","article-title":"Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against Ebola virus and Marburg virus: results of two single-ascending-dose studies","volume":"58","author":"Heald","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023011710424646200_B151","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/504267","article-title":"Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference","volume":"193","author":"Geisbert","year":"2006","journal-title":"J. Infect. Dis."},{"key":"2023011710424646200_B152","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(10)60357-1","article-title":"Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study","volume":"375","author":"Geisbert","year":"2010","journal-title":"Lancet"},{"key":"2023011710424646200_B153","volume-title":"FDA allows expanded use of experimental Ebola drug","author":"Young"},{"key":"2023011710424646200_B154","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.ppat.0030009","article-title":"Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys","volume":"3","author":"Oswald","year":"2007","journal-title":"PLoS Pathog."},{"key":"2023011710424646200_B155","doi-asserted-by":"crossref","first-page":"e36192","DOI":"10.1371\/journal.pone.0036192","article-title":"Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever","volume":"7","author":"Marzi","year":"2012","journal-title":"PLoS One"},{"key":"2023011710424646200_B156","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023011710424646200_B157","doi-asserted-by":"crossref","first-page":"e1575","DOI":"10.1371\/journal.pntd.0001575","article-title":"Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection","volume":"6","author":"Qiu","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2023011710424646200_B158","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.1213709109","article-title":"Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques","volume":"109","author":"Olinger","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023011710424646200_B159","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"2023011710424646200_B160","doi-asserted-by":"crossref","first-page":"g5488","DOI":"10.1136\/bmj.g5488","article-title":"US signs contract with ZMapp maker to accelerate development of the Ebola drug","volume":"349","author":"McCarthy","year":"2014","journal-title":"BMJ"},{"key":"2023011710424646200_B161","volume-title":"Liberia-U.S. clinical research partnership opens trial to test Ebola treatments","author":"U.S. National Institutes of Health"},{"key":"2023011710424646200_B162","volume-title":"Ebola vaccines, therapies, and diagnostics","author":"World Health Organization. W.H.O."},{"key":"2023011710424646200_B163","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S1473-3099(15)00228-5","article-title":"Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers","volume":"15","author":"Jacobs","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"2023011710424646200_B164","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.aad5224","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"key":"2023011710424646200_B165","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.aad6117","article-title":"Structural and molecular basis for Ebola virus neutralization by protective human antibodies","volume":"351","author":"Misasi","year":"2016","journal-title":"Science"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/100\/5\/889\/48717551\/jlb0889.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/100\/5\/889\/48717551\/jlb0889.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T08:36:16Z","timestamp":1677486976000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/100\/5\/889\/6933055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":165,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,9,1]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.4ri0316-099rr","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,11]]},"published":{"date-parts":[[2016,9,1]]}}}